Home›Stock Screener›Hikal›P/E Ratio

Hikal P/E Ratio

Hikal P/E ratio. Hikal (HIKAL) P/E ratio is not applicable — EPS (TTM) ₹-3.96, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.

P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable

Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.

Consecutive Loss Quarters: 1

Current EPS: ₹-3.96

Recent Quarterly Performance

Quarter EPS (₹) Net Profit (₹ Cr) Status
Sept 2026 -0.49 -6 Loss
Mar 2026 1.17 14 Profit
Jun 2026 -0.60 -7 Loss
Sept 2025 -2.83 -35 Loss
Mar 2025 4.07 50 Profit
Jun 2025 -1.82 -22 Loss
Dec 2025 -0.48 -6 Loss
Sept 2024 1.48 18 Profit

Healthcare Peers with Valid P/E Ratios — HIKAL Comparison

Healthcare sector average P/E 52.19, median 29.6 — HIKAL excluded (negative EPS).

Sector Average PE
52.19
Sector Median PE
29.6
Lowest PE
2.0
Profitable Companies
256
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low

Related Analysis